That's what we have here, aided and abetted by people whom I used to respect. I shall be glad when my 50p target is reached and I can say goodbye to this whole sorry saga.
I contacted Suzy re 401 a few weeks back and received an immediate response and a promise to alert me when the Q & A's were available. True to her word, I had an email this morning and my question was included. One of the most communicative & pleasant CEO's on AIM IMO. Most don't care about shareholders. We are in good hands even if the SP isn't where some wish it to be (including me)
This may be a duplicate posting! Hopefully news on the CTA for SDC 1801 this month and I wonder if Sareum received the R & D tax credit of £135k due in January. Would that need an RNS?
Partnership news could come at any time a prospective bidder is satisfied with the process in motion. The value of the partnership deal is likely to increase as more work is done on the compound.
I sense a change in sentiment due to, perhaps, unreasonable expectations. I did think we would have had some progress on 201 and whatever happened to 401?
I read that answer a bit differently in that no exclusivity applies to the Japanese Company and that Valirx " continue to present the project to other companies".
Now that blood sports are banned, lowering the price and watching the resultant howls of anquish, is the only form of entertainment the MM's have. Mind you, works every time on every stock!